Search research articles
Contact Us
Filters
Showing results (291-300 of 652) with videos related to
Page
of 66
Sort By:
Journal of Synchrotron Radiation
|
July 1, 2017
Very efficient spin polarization analysis (VESPA): new exchange scattering-based setup for spin-resolved ARPES at APE-NFFA beamline at Elettra
Chiara Bigi, Pranab K Das, Davide Benedetti, et al.
Scientific Reports
|
July 10, 2018
Radio-frequency current drive for thermonuclear fusion reactors
A Cardinali, C Castaldo, R Cesario, et al.
Journal of Psychiatric Research
|
May 31, 2008
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano, Stefania Bonaccorso, Angelo Ricciardi, et al.
Inflammatory Bowel Diseases
|
February 8, 2026
Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC program
Marla C Dubinsky, María Chaparro, Peter M Irving, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry
Edward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Alimentary Pharmacology & Therapeutics
|
March 20, 2010
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R Panaccione, J-F Colombel, W J Sandborn, et al.
Gastroenterology
|
March 10, 2015
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus
Brian Bressler, John K Marshall, Charles N Bernstein, et al.
Toxins
|
April 16, 2015
Genetics, genomics and evolution of ergot alkaloid diversity
Carolyn A Young, Christopher L Schardl, Daniel G Panaccione, et al.
Crohn'S & Colitis 360
|
July 1, 2025
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis
Remo Panaccione, Faye Chan-Diehl, Simin Baygani, et al.
Journal of Crohn'S & Colitis
|
February 13, 2019
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies
Remo Panaccione, Robert Löfberg, Paul Rutgeerts, et al.
Page
of 66
Search research articles
Search
Showing results (291-300 of 652) with videos related to
Sort By:
Page
of 66
Journal of Synchrotron Radiation
|
July 1, 2017
Very efficient spin polarization analysis (VESPA): new exchange scattering-based setup for spin-resolved ARPES at APE-NFFA beamline at Elettra
Chiara Bigi, Pranab K Das, Davide Benedetti, et al.
Scientific Reports
|
July 10, 2018
Radio-frequency current drive for thermonuclear fusion reactors
A Cardinali, C Castaldo, R Cesario, et al.
Journal of Psychiatric Research
|
May 31, 2008
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano, Stefania Bonaccorso, Angelo Ricciardi, et al.
Inflammatory Bowel Diseases
|
February 8, 2026
Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC program
Marla C Dubinsky, María Chaparro, Peter M Irving, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry
Edward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Alimentary Pharmacology & Therapeutics
|
March 20, 2010
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R Panaccione, J-F Colombel, W J Sandborn, et al.
Gastroenterology
|
March 10, 2015
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus
Brian Bressler, John K Marshall, Charles N Bernstein, et al.
Toxins
|
April 16, 2015
Genetics, genomics and evolution of ergot alkaloid diversity
Carolyn A Young, Christopher L Schardl, Daniel G Panaccione, et al.
Crohn'S & Colitis 360
|
July 1, 2025
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis
Remo Panaccione, Faye Chan-Diehl, Simin Baygani, et al.
Journal of Crohn'S & Colitis
|
February 13, 2019
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies
Remo Panaccione, Robert Löfberg, Paul Rutgeerts, et al.
Page
of 66